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INTRODUCTION 
 
Cerebral venous thrombosis is characterized by clinical 
pleomorphism and pathogenic variability. Though uncommon compared 
to arterial disease, it is an important consideration because of its potential 
morbidity. 
 
       Though recognized over 100 years, it has only recently come to be 
diagnosed  frequently antemortom. This is partly due to greater awareness 
among physicians and neurologists and partly to improved  non invasive 
imaging techniques  especially Magnetic Resonance Venogram. Its 
clinical presentation is often dramatic, mimicking  a variety  of clinical 
conditions. It often afflicts young and middle aged patients, more 
commonly women .Studies have highlighted  greater prevalence of 
disease  in Indian population, more so in pregnancy  and puerperium. 
Though earlier studies have reported higher mortality, recent studies have 
reported lesser mortality due to earlier diagnosis, increased awareness and 
management. 
 
Though it occurs in a setting of a known predisposition to venous 
thrombosis, the proportion of unknown etiology remains higher. Since it 
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presents with a remarkably wide spectrum, it is often difficult to diagnose 
CVT on clinical grounds and requires neuroimaging for diagnosis. MRV 
has taken over cerebral angiography as the diagnostic modality of choice. 
 
          Management of CVT with anticoagulants  especially heparin was a  
controversy in earlier studies , but recent studies  have proved heparin to 
be  both effective  and safe  even with haemorrhagic  infarcts. 
 
         Outcome is unpredictable, mortality is reported to be lesser in recent 
series  
 
This study is targeted to highlight the importance of recognizing 
and diagnosis of CVT at an early stage, to reduce morbidity and mortality 
of this potentially curable disease   
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AIM OF THE STUDY 
 
I . To analyse the commonest clinical modes of presentation 
 
II . To analyse the topography of involved venous sinuses in Magnetic 
resonance venogram. 
 
III . To evaluate clinical outcome.    
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REVIEW OF LITERATURE 
 
HISTORY 
The syndrome of intracranial venous and sinus thrombosis termed 
as Cerebral Venous Thrombosis was recognized in the early part of  18th 
century when Ribes  1 (1825) described in a 45 year old male , the clinical 
and autopsy spectrum of superior sagittal thrombosis. The first ever 
description of superior sagittal sinus thrombosis occurring during 
puerperium was by Abercrombie 2 in 1828. Kalabagh3 in his monograph 
on CVT, stated that aseptic thrombosis is not an uncommon entity 
especially in puerperium and elderly. During the 1940s Sir Charles 
Symonds and Pardon Martin defined the clinical syndrome and provided 
basis for suspecting CVT as an antemortem diagnosis. 
 
INCIDENCE  
The exact incidence of CVT is still under debate because of 
scarcity of scientifically planned epidemiological studies in the available 
literature. With the advent of newer imaging techniques the prevalence of  
CVT is more common than reported previously4,5,6.Aseptic CVT 
occurring in pregnancy and puerperium has been reported very frequently 
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from Indian population. CVT constitutes 10 -15 % of stroke according to 
Indian studies 7,8,9 especially in the young and was the commonest cause 
of stroke in pre-menopausal women. Prevalence in UK is  
4/1000000/year.  Prevalence of postpartum CVT in India is 
4.5/1000/year10 ,11. In Indian population, mutiparas are affected more than 
primiparas in proportion of 4:112. In 1995, Daif reported a frequency of 
7/100000 in cases in Saudi Arabia. It has been estimated that prevalence 
rates of CVT in developing countries is approximately 10 times more 
than in developed countries. Currently aseptic CVT has replaced septic 
CVT as the commonest cause. 
Scanning age related incidence graphs reveal three peaks as follows:13 ,14 
 
1. Infants and children: Probably explained on basis of greater 
prevalence of  dehydration associated diseases, malnutrition, CNS 
infections. 
2. Young pre-menopausal women: Frequent use of oral contraceptive 
pills in developed countries is an important etiological factor, while in 
developing countries pregnancy and puerperium is the commonest 
cause. 
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MORTALITY 
According to British Registrar General 15,  average mortality in UK 
was 0.4/1000000/year i.e 10%. In early literature mortality ranged 
between 30 -50 % 16 ,17,18 whereas it is between 10 -15 %19 ,20, 21, 22  in 
recent series. More recently a Portuguese study group prospectively 
analyzed 91 consequently admitted patients from 1995-1998, of patients  
analyzed 7%  died in acute phase, 1% died during one year follow up, 
82% recovered completely. 59% developed thrombotic events, 10% 
seizures, 11% complained of severe head ache. 
 
ANATOMY23,24 
Knowledge of the venous anatomy is essential to understand the 
pathogenesis, clinical manifestations, prognosis in intracranial sino-
venous disease. The cerebral venous system is unique in being valveless, 
mostly trabaculated, low pressure system. The cerebral venous system 
consists of  
(1)  Dural venous sinuses 
(2)  Cerebral veins 
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CEREBRAL VEINS : Divided into superficial/external group and 
deep/internal group. 
SUPERFICIAL CEREBRAL VEINS :  Arise from cortex and 
medullary substance of hemisphere. 
 
1. Superior Cerebral Veins : 8-12 in number, drain superior, medial, 
lateral surfaces of cerebral hemisphere above sylvian fissure, pierce 
arachnoid membrane and terminate in superior sagittal sinus. 
 
2. Middle Cerebral Veins : Traverse sylvian fissure, drains insula and 
opercular region and terminate in cavernous or spenoparietal sinus. It is 
connected to superior sagittal sinus by the Great anastomotic vein of 
Trolard, and with tranverse sinus by anastomotic vein of Labbe.  
 
3. Inferior Cerebral Veins : Many in number, divided into orbital and 
temporal veins. Orbital veins terminate into superior cerebral veins or 
superior sagittal sinus. 
Temporal veins terminate into cavernous, transverse, superior 
petrosal sinus through middle cerebral veins. 
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DEEP CEREBRAL VEIN : Drain the interior of cerebral hemispheres. 
1. Choroidal Veins : Runs entire length of choroids  plexus, and receives 
branches from hippocampus, fornix and corpus collosum. It joins with the 
terminal vein to form the Internal cerebral vein. 
 
2. Terminal Vein : Runs in the groove between caudate nucleus and 
thalamus. It received many tributaries from these structures as well as 
from the internal capsules.  
 
The two internal cerebral veins join to form the Great cerebral vein 
of Galen, that terminates in the straight sinus. 
 
3. Basal vein of Rosenthal : Formed by the union of anterior cerebral 
vein, deep middle cerebral vein and inferior striate vein. It receives 
tributaries from cingulate gyrus, anterior part of corpus collosum, orbital 
surface of frontal lobe, olfactory groove, optic chiasm, hypophysis, 
cerebral peduncle, inter peduncular fossa, mid brain. 
 
 
 
22 
 
VENOUS SINUSES 
1. Superior Sagittal Sinus : Occupies the falx cerebri. Starts anteriorly 
in the crista galli and ends in the internal occipital protuberance by 
turning to the right side and continuing as the right transverse sinus. It 
receives the superior cerebral veins and the parietal emissary veins. 
 
2. Inferior Sagittal Sinus : Situated in the posterior 2/3 of  falx cerebri. 
It joins the great cerebral vein to form the straight sinus that eventually 
ends in the left transverse sinus. 
 
3. Straight Sinus : Formed by the union of the inferior sagittal sinus and 
the great vein of galen to continue as the left transverse sinus. At the 
termination of the great cerebral vein into the sinus, there exists a ball 
valve mechanism formed by a sinusoidal plexus of blood vessels which 
regulates the secretion of  cerebrospinal fluid. 
 
4. Transverse Sinus : Begins at the confluence of sinus (Torcula 
Heterophili) to pass laterally and forward in the margin of tentorium 
cerebelli to the postero inferior angle of the parietal bone and passes 
down as a sigmoid sinus. It receives blood from the superior petrosal 
sinus, inferior cerebral veins, inferior cerebellar veins. 
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5. Sigmoid Sinus : It is the direct continuation of the tranverse sinus and 
is ‘S’ shaped. It extends from the postero inferior angle of the parietal 
bone to the posterior part of the jugular foramen where it continues as the 
superior bulb of internal jugular vein. Its tributaries are the mastoid veins, 
cerebellar veins, internal auditory vein. 
 
6. Cavernous Sinus : It is a large venous space between the two layers of 
the duramater situated in the middle cranial fossa, one on either side of 
the body of the sphenoid bone. It contains a cranial nerves III, IV, 
V,internal carotid artery, and VI  nerve. Its tributaries are inferior 
ophthalmic vein, central vein of the retina, superficial middle cerebral 
vein, inferior cerebral veins, spenoparietal sinus, and frontal trunk of 
middle meningeal vein. It drains into the transverse sinus through 
superior petrosal sinus, into the internal jugular vein through inferior 
petrosal sinus, into the pterygoid plexus of veins through the emissary 
veins, into the facial vein through superior ophthalmic vein. 
 
7. Superior Petrosal Sinuses  :  Lie in the anterior part of the attached 
margin of tentorium cerebelli along the upper border of the petrous 
temporal bones.These sinuses drain the cavernous sinus into the 
transverse sinus. 
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8. Inferior Petrosal Sinuses :  Lie in the petro-occipital fissures and 
drain the cavernous sinus into the internal jugular vein. 
 
9. Spenoparietal Sinus : Receive the frontal trunk of middle meningeal 
vein and drain into the anterior; part of the cavernous sinus. 
 
FUNCTIONAL ANATOMY23 
1. The cerebral veins and sinuses have neither any valves nor any 
tunica muscularis. Absence of valves permits blood flow in various 
directions , while absence of tunica muscularis permits the veins to 
remain dilated. 
2. Intercommunication between the various venous sinuses provide 
alternative routes by which blood from dural sinuses may flow if 
normal drainage is blocked. 
3. Venous sinuses are located between the two rigid layers of dura 
mater. This prevents their compression when intra cranial pressure 
rises. 
4. Emissary veins from scalp, face, ears, Para nasal sinuses etc and the 
diploic and meningial vein drain directly into venous sinuses and 
thus facilitates spread of infections. For example, superior sagittal 
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sinus thrombosis in scalp infections, cavernous sinus thrombosis in 
facial infections and otitis in lateral sinus thrombosis. 
5. Superficial cortical veins drain into the superior sagittal sinus 
against the blood flow in the sinus, thus causing a turbulence in the 
blood stream that is further aggravated by the presence of fibrous 
septa in the inferior angle of sinus. This explains the greater 
prevalence of superior sagittal sinus thrombosis. 
6. Arachnoid  villi are located  in the walls of superior sagittal sinus 
and drain the cerebrospinal  fluid into the sinus. So any thrombosis 
in the sinus will block the villi and raise the intra cranial tension. 
7. The deep cortical veins form venous circle around the mid brain. 
And get engorged in superior sagittal sinus thrombosis. 
 
ETIOLOGY 
More than 100 causes of CVT have been recorded in scientific 
literature 21. However with extensive investigation no cause is identified 
in 25% cases.24 
CVT can develop because of : 
1. Changes in vessel wall- e.g. Malignancy, infection. 
2. Changes in blood flow-e.g. Stasis. 
3. Changes in blood coagulability : e.g. anti-phospholipid syndrome.  
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CAUSES : 
I. Hyper coagulable causes: Pregnancy, Puerperium 25 ,26 ,27, APLA 28 ,29 
Anti-thrombin III deficiency 29 ,Protein C and S alteration 29,30, 
Factor V Leiden mutation 29, paroxysmal nocturnal haemoglobinuria  
31, Thrombotic thrombocytopenic purpura, Polycythemia 19, Sickle 
cell diseases 32, Hyper homocystinemia33, nephrotic syndrome34, 
Leukemias35,multiple myeloma, waldenstroms macroglobulinemia, 
Budd chiari, DIVC. 
II. Changes in vessel wall: Malignancy 36 ,37 ,38, infections39, 40, 41, 42,43,44 
(Otitis, Facial, Nasolabial, Meningial, Post traumatic) 
III. Changes in blood flow: Dehydration, congestive cardiac failure. 
IV. Drugs 45: Oral contraceptives 46 47, steroids 48, epsilon amino caproic 
acid, L-asparaginase, ecstasy 49,heparin 50.  
V. Others: Inflammatory bowel disease 51, cirrhosis liver ,sarcoidosis 52, 
connective tissue disorder 53 54 55. 
VI. Unknown cause. 
 
POST INFECTIVE/SEPTIC CVT 19, 26 ,27 
Was the commonest cause of CVT in pre antibiotic era. The 
cavernous sinus, lateral sinus, and superior sagittal sinus were commonly 
involved in order. 
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CVT IN PREMENOPAUSAL WOMEN56, 57, 58 ,59 ,60, 61  
CVT in pregnancy and puerperium, is the commonest cause of 
CVT in developing countries and is frequently reported from the Indian 
subcontinent 10. It usually occurs in the last trimester of pregnancy and in 
the puerperium usually within the first three weeks 62. 
 
The contributing factor is hyper coagulability that occurs due to 63 : 
1. Increased clotting factors – I, VII, VIII, X. 
2. Decrease coagulant inhibitors like protein S and C64. 
3. Increased ability to neutralize heparin. 
4. Factor V Leiden mutation65. 
5. Fluid restriction following delivery leading to dehydration and 
changes in blood flow. 
6. Anemia of pregnancy10. 
7. Raised serum triglycerides, decreased fibrinolytic activity66,67, 
increased platelet count and their adhesiveness68 have been observed 
but statistical correlation studies have disproved their role. 
 
 Earlier observations of venous stasis, puerperal sepsis and 
paradoxical embolism through the vertebral plexus as the contributing 
factors for CVT in pregnancy and puerperium have not been established. 
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Post puerperal CVT is found to be more commoner than post gestation 
CVT in Indian studies which also found it to be more prevalence among 
multiparas than primiparas in the ratio of 4:1. 
 
CLINICAL FEATURES 
Varied presentation, determined by: 
1. Underlying venous system involved 
2. Mode of onset-acute / subacute / chronic 
3. Time if interval between disease onset and clinical presentation 
4. Nature of the primary disease giving rise to CVT 
 
AGE : In1992, Ameri and Bousser reported a uniform age distribution 
among men with CVT, while most women were reported in the age group 
of 20-30 years, this may be related to use of oral contraceptives. 
SEX :  CVT is believed to be more common among women than men in 
a series of 110 cases, Ameri detected a female-male ratio of 1.29:1. 
 
SYMPTOMS : 
1. HEADACHE : is almost the universal symptom of primary CVT. It is 
the most frequent and often the presenting symptom. It may be unilateral 
or bilateral and often involves the frontal or temporal regions. Vomitting 
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usually accompanies the headache and is more common among patients 
with raised intracranial tension. The headache results from raised 
intracranial tension and involvement of pain sensitive sinuses. Once 
anticoagulation is begun the headache improves markedly. Thunderclap 
headache resembling subarachnoid hemorrhage is a rare presentation 69. 
Patients presenting with headache as the only sign is rare and usually 
have accompanying neurological signs 70.  
 
2. FEVER : may be prominent in patients with septic CVT ,but may 
occur due to an aseptic thrombotic process. 
 
3. SEIZURES : are very common and often begins early ,may be focal or 
generalized and present in 50% of cases60.Their early appearance is a sign 
of bad prognosis. The seizures may be recurrent and may be followed by 
aphasia and hemiparesis. 
4. FOCAL NEUROLOGICAL DEFICITS  : comprises  hemiparesis  
usually with facial sparing ,as facial area is drained by slyvian vein. The 
lower limb is affected more often than upper limbs58. In some cases of 
superior saggital sinus the contralateral cortical veins may be involved 
giving rise to contralateral paraparesis or paraplegia 59,61.  
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Cortical deficits like aphasia , apraxia, agnosia are not uncommon and are 
fleeting in nature. 
 
5. CRANIAL NERVE SYMPTOMS : usually due to raised intracranial 
tension and septic CVT involving cavernous sinus. Obscuration of vision, 
double vision, facial weakness, deafness, tinnitus may be the presenting 
complaints. 
 
6. COGNITIVE DYSFUNCTIONS: drowsiness, irritability, confusion, 
varying degrees of coma. 
 
7. OTHERS : psychiatric disturbances, akinetic mutism, fluctuating 
blood pressure. 
 
SIGNS : 
1.  Variable conscious state-fully conscious to coma. 
2. SUPERIOR SAGGITAL / LONGITUDINAL SINUS 
THROMBOSIS 60 :  Headache, vomiting, papilloedema , hemiplegia, 
cortical type paraplegia 3.  
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3. LATERAL SINUS THROMBOSIS (transverse and sigmoid 
sinuses) : Fever, headache ,mastoid swelling, lower cranial nerve 
involvement if  thrombus   involves jugular foramen. 
4. CAVERNOUS SINUS THROMBOSIS 27: As it is usually post 
infective ,its incidence has decreased with advent of antibiotics. 
Recently there has been a spurt in its incidence due to emergence of 
drug resistant organisms and immunosupressive disorders .Sources 
of  pyogenic organisms are nasolabial territories and para nasal 
sinus. 
 Fever, retro orbital pain, chemosis, proptosis, orbital congestion, 
III,IV,VI nerve involvement causing ophthalmoplegia, blindness due 
to optic nerve involvement, papilloedema, hemiparesis due to 
internal carotid artery involvement. 
5. CEREBRAL VEIN THROMBOSIS: Superficial vein thrombosis : 
partial seizures, hemiparesis , aphasia. Its involvement alone without 
extension into dural sinuses is rare and lacks features of raised 
intracranial tension71. 
 Deep cerebral vein thrombosis 72: involvement is rare ,accompanied 
by impaired consciousness, abnormalities in eye movements 
,papillary reaction, fluctuating blood pressure, quadriparesis. 
 
32 
 
 The cerebellar veins 73, may occasionally be involved in relation to 
middle ear infections leading to slowly evolving syndrome of 
vertigo, vomiting and ataxia. 
 
6.  PUERPERAL CVT: Depending on the venous sinus involved, 
clinical picture is usually of headache, seizures, focal deficits, 
papilloedema . Sometimes patients may present with headache and 
papilloedema without focal deficits simulating a brain tumour-
pseudo tumour cerebri 35 The onset of symptoms in 80-90% of CVT 
is within the 1st-2nd week of delivery. Presentation 3months 
following delivery has been observed in studies by Nagpal in 1983. 
A large number of affected persons are multiparous 12 according to 
Indian studies (Banerjee, 1973; Bansal,1980; Srinivasan, 1983). 
According to a U.S. based survey of puerperal CVT 63, a significant 
risk was with cesarean section, increasing maternal age, hyperemesis 
,maternal hypertension, intercurrent infections .The association of 
hypertension with puerperal CVT has not been reported with other 
studies. 
Based on the experience of dealing with large number of cases of CVT 
Indian studies have grouped clinical pattern of CVT as follows: 
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GROUP-I : Meningo encephalitic type :headache ,fever ,seizures ,altered 
sensorium, focal deficits, meningeal signs. 
GROUP-II : Acute fulminant type :status epilepticus, coma. 
GROUP-III : Pseudo tumour type : headache ,vomiting , papilloedema. 
GROUP-IV : Neuropsychiatric type : abnormal behaviour, with or 
without features of raised intracranial tension. 
In a recent Dutch European study 22, the most frequent symptoms and 
signs were : 
  1. Headache                            -  95% 
 2. Papilloedema                     -  49% 
 3. Seizures                              -  47% 
 4. Motor/sensory deficits       - 34% 
 5. Changes in consciousness    - 30% 
 6. Dysphasias                           - 12% 
 7. Cranial nerve palsies            - 12% 
 8. Nystagmus                       - 2% 
 9. Deafness                            - 2% 
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PATHOLOGY 74 : findings are determined by following factors: 
   1. Underlying disease pathology 
   2. Nature of venous sinus/cerebral vein involved 
   3. Interval between onset and pathological examination 
 
Cortical vein thrombosis : 
    Presents as a cord like swelling with very minimal hemorrhagic 
infarction of the brain. This is due to the presence of frequent 
intercommunications between various cortical veins and sinuses. 
 
Superior sagittal sinus thrombosis: 
    Sinus appears distended and blue. Cortical veins also get ruptured 
giving rise to intracerebral hemorrhage. In an occasional case, 
hemorrhagic infarction may appear on the other side due go occlusion of 
opposite cortical vein. 
 
Deep cerebral vein thrombosis :  
White matter area of brain gets involved , especially the regions of 
basal ganglia and thalamus. As times progresses the thrombus gets 
recanalised, organized and may even disappear in majority .Cerebral 
edema due to venous flow obstruction may lead to transtentorial 
herniation with notching of uncus. 
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COMPLICATIONS : 
1. Increasing venous congestion raises cerebrospinal pressure if 
collateral drainage is insufficient 75. 
2. Parenchymal edema with venous infarction, hemorrhage complicates 
50% cases 24. 
3. Seizures may persist requiring continued anti epileptics. 
5. Pulmonary embolism is uncommon but carries a poor prognosis. A 
review of literature    between 1942-1990 revealed in 11.3% cases of 
venous sinus thrombosis was associated with pulmonary embolism 
and in these cases the overall mortality was 95.6%, far higher than 
those without embolism76. 
6. Hypopituitarism may result from cavernous sinus thrombosis 77. 
7. Dural sinus thrombosis was associated has been cited by several 
authors as an aetiological association with dural A-V fistulas, 
although it may be difficult if the thrombosis was the primary or 
secondary event 78.  
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DIAGNOSIS 
Requires a high index of suspicion 
Objectives of investigation are: 
1.  Diagnosis of cerebral vein or sinus thrombosis. 
2. Identification of the involved sinus or vein involved. 
3. Identification of the underlying pathogenic factors. 
 
I.   C.T.SCAN BRAIN79 ,80  
It is often the first investigation obtained. It may show both direct 
and indirect signs of cerebral venous thrombosis .It is also helpful to rule 
out other causes of patients clinical condition like neoplasm, abscess, 
arterial stroke.C.T.brain  may be normal in 20% cases16.   
The direct signs are due to thrombosis of sinus or vein , the indirect 
signs are due to secondary effects of thrombosis on parenchyma 81. 
 
 A. DIRECT SIGNS : the two signs reported as pathognomonic of 
C.V.T ,the cord and delta signs are found in only minority of cases 82. 
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Plain C.T 
CORD SIGN 83 ,84 : represents the thrombosed cortical vein. It appears as 
a linear hypodense streak in location of involved vein. It represents acute 
or new thrombus ,thus seldom seen in chronic cases. 
DENSE TRIANGLE SIGN 83 ,84 : triangular area of increased density 
along course of superior sagittal sinus and represents opacification by 
freshly coagulated blood. It is rare and usually seen in the first two weeks 
of the disease. 
 
Contrast C.T 
DELTA /EMPTY TRIANGLE SIGN16 : it is a triangular rim of 
contrast surrounding a clot within the superior sagittal sinus ,giving 
appearance of Greek letter delta. It is the most frequent sign present in 
30% of cases .This sign appears after first 3-5 days of disease onset .Early 
division of superior sagittal sinus can be some times be responsible for 
false delta sign.  
 
B. INDIRECT SIGNS : they are frequent and include : 
1.  Intense contrast enhancement of falx and tentorium, a sign of 
straight and superior sagittal sinus thrombosis. Seen in 20% cases 
and indicates venous stasis and hyperemia of the duramater. 
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2.  Single or multiple areas of intense gyral enhancement. 
3. Brain oedema-may be unilateral or bilateral. Seen in 25-50% cases. 
It is characterized by white matter hypodensity on C.T, compressed 
ventricles ,obliterated cisterns, effaced sulci. 
4. Venous infarcts : seen in 10-15% cases .Can be unilateral or 
bilateral, hemorrhagic or non hemorrhagic. 
 Hemorrhagic infarct appears as hyperdensities within hypodense 
infracted zone plain C.T. Both petechial hemorrhages as well as 
large hematomas may be encountered. Superior sagittal sinus 
produces frontal or parietal infarct. Lateral sinus thrombosis 
produces temporal lobe infarct. Diencephalic or basal ganglionic in 
infarcts deep cerebral vein thrombosis.  
 
 Non hemorrhagic infarct appears as focal areas of hypodensities on 
C.T. 
 Venous infarcts are differenciated from arterial infarct as follows: 
*More often hemorrhagic 
*Do not confirm to any arterial territory.   
*Have ill defined margins. 
*Have greater mass effect for the size of infarct. 
5. Hydrocephalus:due to raised intra cranial tension in superior sagittal 
sinus thrombosis. 
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II. MAGNETIC RESONANCE IMAGING / MAGNETIC 
RESONANCE VENOGRAM 85 
In 20% cases C.T. scan can be normal. The use of MRV has led to 
early, accurate and non invasive diagnosis of C.V.T.MRV has replaced 
invasive cerebral angiography as the investigation of choice for CVT 86. 
 
Findings  : depends on the age of the thrombus 
*If the venous sinus or cerebral veins are acutely thrombosed , there is no 
signal or flow at the anatomical site of the vein .The absence of flow can 
also result from anatomical absence of vein , so it is necessary to perform 
axial/sagittal T1/T2 weighted MRI. 
 
*On T1 and T2 weighted images, the acute thrombus appears isointense 
onT1 and hypointense on T2.Few days later the thrombus becomes 
hyperintense on T1 and T2 weighted images. 
 
*Two weeks later the thrombus reduces in size with recanalization and 
resumption of normal flow void. 
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ADVANTAGES: 
*Sensitive to blood flow changes and helps visualize the thrombus. 
*More sensitive than C.T.in detecting parenchymal changes particularly 
microhemorrhages ,considered hall mark of venous infarct 87 ,75. 
*Demonstrate underlying cause such as tumours or unsuspected 
mastoiditis. 
 
DISADVANTAGES : 
Difficulty in diagnosis may arise due to normal anatomical variants 88. 
Commonest venous channels involved in CVT in MRV are 85: 
1. Superior sagittal sinus thrombosis - 72% 
2. Transverse sinus thrombosis - 70% 
3. Straight sinus - 14% 
4. Deep sinus - 8% 
5. Cavernous sinus - 3%. 
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III. CEREBRAL ANGIOGRAPHY  
Invasive test, was regarded as the investigation of choice for CVT, 
now replaced by MRI/MRV.A four vessel angiography with venous 
phase films taken at intervals of 5-12 seconds of contrast injection. 
Frontal, lateral, oblique views are taken in order to visualize the entire 
venous system. Delayed venous films may be necessary to allow for slow 
venous filling in patients with raised intracranial tension .Angiography 
becomes necessary if thrombolytic therapy is considered. 
 
FINDINGS : 
1. Failure to demonstrate all or part of sinus/vein or localized 
irregularity within its wall. 
2. Non filling of cortical veins 
3. Focal or diffuse slowing of circulation and stagnation of coagulated 
blood in capillary or venous phase. 
4. Corkscrew vessels that do not reach cortical surface due to dilatation 
of anastomotic vein over cortex. 
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5. Parenchymal changes include: 
         -Focal or diffuse brain swelling with sulcal effacement and chinked 
ventricles in severe cases. 
         -Intracranial hemorrhage as a result of intra luminal pressure 
exceeding the structural limit of vessel wall 
       -Ventriculomegaly due to decreased cerebrospinal fluid, a 
consequence of increased resistance of CSF resorption by the 
arachnoid granulations. 
While reviewing angiogram films following points to be remembered : 
*Venogram films may be normal due to well developed collaterals 
*Recanalisation of sinus may also yield false negative angiogram. 
*The Vein of Galen may not be visualized in patients with raised 
intracranial tension. 
*Non visualisation of sinus may be due to anatomical variation  
*Narrow anterior part of superior sagittal sinus is often poorly visualized 
at angiography and its isolated lack of filling is not sufficient to indicate 
thrombosis. 
*Cavernous sinus are rarely visualized on angiogram. 
*Similarly an isolated lack of filling of transverse portion of the left 
lateral sinus is more suggestive of hypoplasia than thrombosis.In one 
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study transverse portion of lateral sinus was not visualized in 14% cases 
on left and 33% cases on right. 
IV. RADIONUCLIDE SCANNING 89 
Dynamic radionuclide scanning has been utilized for visualization 
of venous dural sinuses, but lacks sensitivity and specificity. 
 
V. OTHER INVESTIGATIONS 
1. CSF examination 19 : not of diagnostic use .It is performed in 
suspected meningitis .It may reveal non specific changes like raised 
proteins ,cells and pressure. 
2. Appropriate tests towards aetiogenesis like : 
 *Complete blood count-may reveal 
anemia,polycythemia,leucocytosis,thrombocytopenia. 
 *Lupus anticoagulant and anti cardiolipin antibodies. 
 *Protein C and S,Antithrombin III, FactorV Leiden mutation 
 *Sickle cell preparation 
 *ESR, ANA tests in connective tissue disorder 
 *ANCA in wegeners granulomatosis 
 *Urine for protein 
 *Liver function tests 
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 *D-dimer 90-in a prospective study of 54 patients with headache 
suggestive of CVT Lalive found 12 had CVT,10 had D-dimer of 
>500ng/ml. The 2 patients had chronic headache >30days. D-dimers 
were positively correlated with the extend of thrombus and 
negatively correlated with duration of symptoms. 
 *EEG-abnormal in 75%cases.Changes are nonspecific and include: 
 -Focal or diffuse hemispheric slowing. 
  -Focal or generalised epileptic activity 
  EEG may not add to the diagnosis but may guide seizure 
management in long run. 
 
MANAGEMENT : 
Aim of treatment is to: 
1. Provide symptomatic relief to patients. 
2. To prevent further extension and recurrence of thrombus. 
Treatment is based on: 
1. General therapy 
2. Symptomatic therapy 
3. Specific therapy. 
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GENERAL MEASURES : 
Include routine measures for care of comatose patient and includes: 
*Maintenance of airway patency. 
*Maintenance of fluid and electrolyte balance. 
*Prevention of infections and gastric ulcers. 
SYMPTOMATIC TREATMENT : 
1. Seizures : antiepileptics are obviously indicated in patients with 
clinical seizures. However controversy exists regarding: 
 *Prophylactic use of anticonvulsants in all patients with CVT. 
 *The duration of therapy, once antiepileptics are started-may range 
from 2-5 years. Ideally a one year seizure free interval is reasonable. 
2. Cerebral oedema : cytotoxic edema results due to alteration in 
biochemical mechanism at cellular level. It is followed by vasogenic 
edema in 24-48 hours .Measures to control cerebral edema and 
raised intra cranial tension are : 
 *Head end elevation to 30 degrees to promote venous drainage. 
 *Mannitol(20%)-in dose of 0.25-1g/kg i.v over period of 10minutes 
 *Dexamethasone therapy is of unproven efficacy but can be given in 
a dose of 4mg every 6 hours.It primarily reduces vasogenic edema. 
 *Hyperventilation to bring partial pressure of carbon dioxide to                
25-30mmhg to reduce intracranial pressure in life threatening 
situations. 
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 *Other agents/ measures used are-glycerol, acetazolamide, shunting 
and even barbiturate induced coma. 
 *The choice among these methods depends on the clinical situation. 
If the level of sensorium deteriorates or if the headache is severe 
mannitol is preferred. 
 *Surgical decompression will be required in cases of continuing 
deterioration inspite of maximum medical management.   
3. Infections : appropriate antibiotics. 
SPECIFIC THERAPY : 
I. ANTICOAGULANT THERAPY: with heparin was first advocated 
for venous thrombosis 50years ago 32. Its use in CVT has been debated 
for long  time. In the past , the main arguments cited against its use were 
presence of hemorrhagic infarction, subarachnoid hemorrhage. 
Scientifically planned studies have generated enough evidence in favour 
of heparin use and thus has emerged as a useful drug in management of 
CVT 91, 92 ,93. In the past anticoagulation was mainly reserved for patients 
with coexistent deep vein thrombosis, pulmonary embolism and 
prothrombotic states. Currently anticoagulation with heparin either 
intravenous/subcutaneous is indicated for all cases of CVT with or 
without hemorrhagic infarcts provided there is no general contra 
indications for its use 94 95. Neonatal CVT is the only situation in which 
heparin has not been shown to improve the outcome and most authors do 
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not recommend its use in this situation (Nagaraja, Sarma 2002).  Heparin 
reduces both morbidity and mortality in CVT96, 97. Anticoagulants are 
used to prevent propagation of the clot to more extensive areas of cerebral 
venous system and thereby prevent progression of infarction. 
 
A. HEPARIN : Increases the action of antithrombin III, leading to 
inactivation of coagulation factors thrombin, factor Xa and IXa. 
DOSE : Most studies have used higher doses of heparin.  
The dose of heparin used should result in aPTT twice of the baseline. 
Both low molecular and unfractionated  heparin are equally efficacious. 
Heparin is given parenterally for 2 weeks followed by oral anticoagulants 
for 3-6 months. Unfractionated heparin can be given either by 
subcutaneous or continuous IV infusion.   
 
The results of two prospective trials conducted at the National 
institute of mental health and neurosciences support the use of low dose 
of heparin-15,000u/day subcutaneously in three divided doses in 
puerperal CVT.  
Dose of continuous infusion is as follows : 
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80u/kg body weight bolus, 18u/kg/hr IV; aPTT checked in six 
hours and every six hours after any dosage change, adjust according to 
following parameters. 
aPTT <1.2 times control  – 80u/kg/hr; increase by 4u/kg/hr 
aPTT 1.2 to 1.5   -  40u/kg/hr; increase by 2u/kg/hr 
aPTT 1.5 to 2.3   -  no change 
aPTT 2.3 to 3   -  decrease by 2u/kg/hr 
aPTT > 3    -  hold infusion for 1hr, decrease by  
3u/kg/hr 
A more recent multicentric double blind placebo controlled trial of 
Nadroparin, a low molecular weight heparin by de Bruijn and Stam 
(1999) randomized 59 patients to receive Nadroparin and placebo for 
three weeks followed by oral anticoagulation for 3 months. After 12 
weeks, 13% of Nadroparin and 21% in placebo group had poor outcome.      
Contraindications for heparin use includes-documented 
hypersensitivity, active bleeding, coagulopathies, endocarditis, 
hemophilia, thrombocytopenia.  
 
B. WARFARIN : interferes with the action of vitamin K, a cofactor 
essential for converting precursor proteins into factors 2,7,9,10. Does not 
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affect activity of coagulant factors synthesized prior to exposure. It used 
for 3-6 months following parenteral heparin. 
 
Dose is 5mg/day, dose adjusted by monitoring prothrombin time 
and INR. Target INR is 2.5. Patients are then reevaluated at end of six 
months with magnetic resonance venogram to see if flow has been 
established. 
Contraindications in documented hypersensitivity, pregnancy, 
active bleeding, vitamin K deficiency. 
 
Prolonged anticoagulation therapy may be required in refractory 
cases or those with underlying prothrombotic state. In patients with 
previous post partum CVT, the use of prophylactic heparin in the 
subsequent postpartum period is not warranted. 
   
II. THROMBOLYTICS : use of systemic anticoagulants for sinus 
trombosis was first used 30 years ago using Urokinase 98.There followed 
a series of open case studies using local infusions either through a frontal 
burr hole or more usually selective catheterization 99. 
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Various techniques of achieving thrombolysis include 
pharmacotherapy with urokinase or rtPA, mechanical thrombolysis, 
rheolytic thrombectomy. 
 
Recombinant tissue plasminogen activator (rtPA/ALTEPLASE), 
has theoretical advantage in mechanism of action over Urokinase 21.Two 
series totaling 21 patients have been reported in literature of its use in 
dural sinus thrombosis 100 ,101, administered through jugular catheter. In 
most cases outcome was good .Local rtPA carries undoubted risk of 
increased symptomatic hemorrhage. 
 
Thrombolysis causes clot lysis. All agents are directly instilled into 
the sinus at time of surgery or use of microcatheters to reach venous 
sinuses. 
 
1. ALTEPLASE : converts plasminogen into plasmin, which degrades 
fibrin, fibrinogen, factor V and VIII. Dose is 1mg/cm infused through 
venous catheter, then 1-2mg/hour. 
 
2. UROKINASE : dose is 2,50,000u/hour; additional doses of 
50,000u;total dose 1,000,000.over 2hours. 
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3. STREPTOKINASE :  dose is 1000-3000u/kg bolus,1000-
1500u/kg/hour. 
 
Contraindications to the above thrombolytics  are : documented 
hypersensitivity, active bleeding ,severe hypertension ,trauma/surgery in 
previous 10 days, coagulopathy, endocarditis etc. 
 
Rheolytic thrombectomy makes use of Bernoulli effect to create a 
vacuum that fragments and aspirates the thrombus. This has the added 
advantage of lack of hemorrhagic complications and potential for use 
even in hemorrhagic CVT.  
Further studies on thrombolytics are in progress 102. 
 
III. ANTIPLATELET AGENTS : have been advocated but never been 
systematically studied. 
 
IV. SURGERY : surgical  decompressive  craniotomy, thrombectomy 
and evacuation of  intracerebral  hematoma need further evaluation before 
it is recommended as a safe procedure103 .Out comes are usually poor 104. 
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In conclusion, patients need to be treated with heparin, even in 
those with pre existing hemorrhage .Failure to respond to therapy 
indicated by deepening coma or CNS deficits despite adequate 
heparinization should be treated with local thrombolytics. 
 
PROGNOSIS : highly variable. 
1. Poor  Outcome : a recent study Dutch venous sinus thrombosis group 
looked at the prognostic factors in a series of 59 cases 22,poor outcomes 
was associated with: 
*Very young/advanced age. 
*Patients presenting with coma or rapid clinical course. 
*Papilloedema 
* Diagnostic delay>10days 
*Intracerebral hemorrhage 
*Involvement of deep cerebral and, cerebellar veins, straight sinus 
Other studies, have suggested poor outcomes with the above parameters 
and others such as:105 ,106 
*Uncontrolled seizures 
*Pulmonary embolism 
*Infections or malignant etiology. 
2. Good outcome : 
53 
 
 *Isolated intracranial hypertension at presentation 
 *Delta sign(perhaps due to early diagnosis) 
 
Follow up in Dutch group found that in one year 107: 
35%had cognitive impairment, 6%were dependent, 40% had 
symptoms that led to restriction of life style,40%could not resume their 
previous level of economic activity. This suggests that there may be more 
morbidity after CVT than previously reported, interestingly there was no 
significant effect of treatment on this later outcome data. 
 
RECURRENCE  
Little is known about the risk of recurrence, although one study 
reports a risk as high as 12% 106. Patients also have increased risk of 
(14%) venous thrombosis elsewhere in the body. Studies following 
recanalisation of venous sinus have shown that it can be incomplete in 
certain cases 108 .Raised intracranial pressure may persist following acute 
presentation of thrombus75. One study has shown that thus results in 
number of significant cognitive or visual disturbances109.    
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MATERIALS AND METHODS 
 
A prospective study, involving a series of 50 women presenting 
with clinical symptoms suspicious of cerebral venous thrombosis 
admitted at Coimbatore Medical College Hospital over a period of 1 ½ 
years – from January 2006 -  June 2007 was analysed, patients were 
followed up for three months following discharge at Medical OPD.  
 
A detailed history with respect to presenting complaints was taken. 
History of fever, bedridden state, dehydration, thrombotic and 
haemorrhagic tendencies, recurrent pregnancy loss were noted. Obstetric 
history was also taken. Patients vital parameters were assessed. General 
physical examination, CNS and other systemic examinations were done 
in the conventional way.  
 
All patients underwent laboratory testing with complete blood 
count  with peripheral smear , blood urea , serum creatinine , liver 
function tests , coagulation profile ( PT, APTT ) , serology for VDRL and 
HIV , CSF  studies  unless contraindicated. All findings were recorded in 
the proforma. 
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Neuroimaging studies were carried out in all patients, initially with 
cranial CT to rule out other causes of patients presenting complaints and 
to note any changes of CVT. All patients were further assessed with 
MRV. 
 
Detailed analysis of the data was done with a view to find out the 
commonest clinical mode of presentation, topography of involved venous 
sinuses in the magnetic resonance venogram. All patients were treated 
with anticoagulant unfractionated Heparin 5000 units intravenously 8th 
hourly and outcome at discharge was assessed as good ( when alive with 
full functional recovery) and poor (death, partial functional recovery). 
 
INCLUSION CRITERIA   
1) Female patients  
2) Age  more than 13 years with clinical symptoms suggestive of 
cerebral venous thrombosis.  
 
EXCLUSION  CRITERIA  
1) Female patients of age < 13 years  
2)  All cases with head injury, neoplastic brain diseases  
  
58 
 
CT CONTRAST  
DELTA SIGN 
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CT BRAIN - PLAIN 
LEFT PARIETO TEMPORAL HEMORRHAGIC VENOUS INFARCT  
 
 
MRV 
RIGHT PARIETO TEMPORAL HEMORRHAGIC VENOUS INFARCT  
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MRV 
LEFT TRANSVERSE AND SIGMOID SINUS THROMBOSIS  
 
 
 
MRV 
LEFT TRANSVERSE AND SIGMOID SINUS THROMBOSIS  
 
Superior sagittal 
sinus 
Transverse sinus 
Sigmoid  sinus 
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OBSERVATION AND RESULTS 
 
Analysis of 50 female patients presenting with clinical symptoms 
suspicious of Cerebral Venous Thrombosis, admitted at Coimbatore 
Medical College and Hospital, between January 2006 to June 2007, who 
met the inclusion criteria was done. 
 
AGE WISE DISTRIBUTION OF CASES 
Total cases -  50 
AGE GROUP
(yrs) 
NUMBER OF 
CASES PERCENTAGE 
18 -  21                18             36 
22 -  25                20             40 
26  -  29                7             14 
30 -   33                3              6 
34  -  37                2              4 
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76% of patients presented in the age group between 18 – 25 years. 
Average age of patients presenting in the study is 24 years with a 
Standard Deviation of 4.05. 
 
Applying the Students T  test  T value = - 2.63 with a   “p  value of < 
0.01  which is statistically significant.  
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CASE DISTRIBUTION 
 NUMBER PERCENTAGE 
PEURPERAL          47            94 
NON PEURPERAL           3 6 
 
Out of 50 patients analysed 47 cases were puerperal and 3 were non 
puerperal . 
Applying the Students T test , T = 1.49 and p = 0.06 , which is close to 
statistically significant 
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CASE DISTRIBUTION BASED ON PARITY 
IN PEURPERAL CVT 
          PARITY          NUMBER    PERCENTAGE
PARA 1                20            42.6 
PARA 2                 19            40.4 
PARA 3                  5            10.6 
PARA 4                  3             6.4 
 
On analyzing the case distribution of puerperal cases of CVT based on 
parity it was found that, it was more prevalent among multipara , 57.5% 
of cases . Among the multiparous it is more common in second parous . 
None of the patients were antenatal at presentation 
CASE DISTRIBUTION BASED ON PARITY
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PEURPERAL CVT : TIME OF PRESENTATION 
Total cases - 47 
POST PARTUM  PERIOD NUMBER PERCENTAGE 
1ST  WEEK 6 12.8 
2ND WEEK 31 66 
3RD WEEK 6 12.8 
4TH WEEK 4 8.4 
 
On analyzing the time of presentation in the puerperal cases it was found 
that 66% of cases presented in 2nd week . 
On applying the Students T test , T = 4.63 with a p value of < 0.01 
which is statistically significant  
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CLINICAL MODES OF PRESENTATION 
                                        
PRESENTING SYMPTOMS   NUMBER PERCENTAGE 
Headache ( H) + seizures ( S ) 21 42 
Headache (H) + seizures (S) 
+altered sensorium (AS) 
4 8 
Headache (H) + Focal 
neurological deficits (FND) 
2 4 
Headache (H) + seizures (S) 
+focal neurological deficits 
(FND) 
3 6 
Headache (H) + visual 
disturbances (VD) 
9 18 
Headache (H) 5 10 
Seizures (S) 1 2 
Headache (H) + Focal deficits 
(FND) + visual disturbances 
(VD) 
1 2 
Headache (H) + seizures (S) + 
visual disturbances (VD) 
1 2 
Focal deficits (FND) 1 2 
Seizures (S) + altered sensorium 
(AS) 
1 2 
Headache (H) + seizures 
(S)+altered sensorium(AS) 
+focal deficits (FND)  
1 2 
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On analyzing the commonest clinical mode of presentation it was 
found that headache was the universal symptom in 47 cases (94 %). The 
headache occurred commonly in association with other symptoms like 
seizures, visual disturbances, focal deficits and altered sensorium.  In 5 
(10%) it occurred in isolation. On applying the Student T test,                
T value  = - 0. 57 which is statistically significant.  
 
Of the cases presenting with seizures, 32 cases, 23 had generalized 
seizures and7 had focal seizures. The ten cases presenting with visual 
disturbances presented with visual blurring. 
 
All the 8 cases of focal deficits presented in the form of 
hemiparesis. 
None of the cases presented with quadriparesis or paraparesis. 
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CLINICAL SIGNS 
SIGNS NUMBER PERCENTAGE 
     PAPILLEDEMA(P) 20 40 
FOCAL DEFICITS(FND) 
( hemiparesis) 
9 18 
PAPILLEDEMA + 
ALTERED SENSORIUM 
(stupor) (AS) 
4 8 
ALTERED SENSORIUM 
(coma) 
1 2 
FND  + AS ( coma ) 1 2 
FND  +  P  3 6 
FND + P + AS 1 2 
NO SIGNS 11 22 
 
On analysis of the clinical signs it was found that 28 cases, 56% , 
had papilloedema, of which 20 had only papilloedema,4had papilloedema 
associated with altered sensorium, and 3 had associated hemiparesis. Of 
the 14 cases presenting with hemiparesis, 3 cases had facial weakness             
(7th nerve palsy). No other cranial abnormality was detected. 
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C T  FINDINGS 
FINDINGS NUMBER PERCENTAGE 
NORMAL 10 20 
DELTA SIGN 10 20 
VENOUS INFARCT 26 52 
DELTA SIGN + VENOUS 
INFARCT 
4 8 
 
On analyzing the CT findings, it was found that 26 cases, 52%, had 
venous infarcts and all the infarcts were hemorrhagic. On applying the 
Students T test – T= 0.3, statistically significant. Nearly 10 cases, had 
normal CT. 
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FINDINGS  ON MAGNETIC RESONANCE VENOGRAM 
VENOUS SINUS / 
CEREBRAL VEIN 
NUMBER PERCENTAGE 
Superior Sagittal Sinus ( S S S )              11             22 
Transverse  Sinus   ( T S )               2              4 
S S S   +  T  S                 15               30 
Transverse Sinus (T S ) + 
Sigmoid  sinus ( Si S ) 
              9               18 
S S S + TS + Si S              10               20 
S S S + TS + Si S + Cortical 
veins (CV) 
               1 
 
                2 
 
Deep Cerebral Vein (DCV)                1                 2       
C V                 1                 2 
 
 On analyzing the topography of involved venous sinuses on 
Magnetic Resonance Venogram it was found that 37 cases, 74 %, had 
involvement of Superior Sagittal  Sinus. 
 
 
37 cases had Transverse sinus involvement, 2 cases in isolation and 
the rest 35 cases in association with involvement of other venous sinuses. 
parenchymal changes in the form of haemorrhagic venous infarcts, 
edema, minimal haemorrhages were noticed in 16 cases. None of the 
cases had involvement of cavernous sinus. 3 cases had extension of 
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thrombus into internal jugular vein, 1 case in to straight sinus and vein of 
Galen. 
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M R V FINDINGS IN PATIENTS WITH NORMAL CT 
VENOUS SINUS/ 
CEREBRAL VEIN 
NUMBER PERCENTAGE
S S S 1 10 
T S 1 10 
S S S + T S 1 10 
S S S+ T S + Si S  5 50 
Si S + T S 2 20 
 
Of  the 10 cases with normal CT scan , all the 10 had findings in 
MRV, 50% of which had involvement of multiple venous channels. 
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PROGNOSIS 
 NUMBER PERCENTAGE 
GOOD 46 92 
POOR 4 8 
 
On analyzing the prognosis of patients at discharge it was found 
that 92 % had good prognosis and 8% had poor prognosis (death). 
Applying Students T test, T= 0.78, which is statistically significant.             
Of the 4 cases, 3 cases had presenting symptoms of headache, 
seizures and altered sensorium and one case had headache, seizures and 
focal deficits. 2 cases had involvement of S S S, one case SSS + TS, and 
one case of deep cerebral vein. 
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OBSERVATION BASED ON LAB PARAMETERS : 
On analyzing the lab parameters, anaemia was found in 15 cases, 30 % , 
of which 14 cases were in peurperium. 
Peripheral smear in all 15 cases showed microcytic hypochromic picture  
None of the patients had thrombocytosis or leukocytosis  
Metabolic parameters like urea , creatinine and LFT and sugar values 
were normal  
Coagulation profile – PT and APTT were normal  
CSF analysis done in 22 cases were normal  
ELISA for HIV and VDRL testing done in all cases were negative  
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COMPARISON WITH OTHER STUDIES 
IN RELATION TO AGE 
 
 
 
 
IN RELATION TO CLINICAL SIGNS/ SYMPTOMS 
 
IN RELATION TO MORTALITY 
AMERI ET AL , 1992 AVG AGE – 20  - 30 
YRS 
PRESENT STUDY AVG AGE  -  18 – 25 
YRS 
SYMPTOMS 
DUTCH – 
EUROPEAN 
STUDY 2001 
MEHTA / 
MUTHU-
KRISHNAN 
2004 
PRESENT  
STUDY 
 
HEADACHE 95% 90% 94% 
SEIZURES 47% 50% 64% 
PARESIS 43% 9% 28% 
PAPILLEDEMA 41% 78% 56% 
ALTERED 
CONSCIOUSNESS 39% - 14 % 
RAISED 
INTRACRANIAL 
TENSION 
22% - 18% 
PROGNOSIS 
WASAY 
ET AL 
2001 
PRESENT  
STUDY 
GOOD       92     92 
POOR   /    DEATH         8      8 
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DISCUSSION 
Cerebral venous thrombosis though not rare, is often undiagnosed 
as it presents with a wide array of symptoms .It mimics practically all 
neurological conditions. It affects all age groups and has unpredictable 
outcome. This condition is common in the Indian subcontinent, 
responsible for 10-15% of young strokes .It has been reported more 
commonly in women. Studies by various Indian authors (Agarwal1978, 
Srinivasan1983, Banerjee1973, Nagarajan 1988) have highlighted higher 
prevalence in pregnancy and puerperium. 
 
In the present study 94% of cases were puerperal (p<0.06-
statistically significant). Though no uniform age group has been reported 
in many studies, most cases of CVT in women were reported in  the age 
group of 20-35years,commonly related to pregnancy & puerperium  and 
oral contraceptive use .In the present study mean age of presentation was 
24 years (p<0.01-stastistically significant). 
 
Low socio-economic status, poor antenatal care, lack of iron 
fortification , fluid restriction and blood loss during pregnancy over and 
above the physiological changes ,have been proposed by various authors 
as the contributory cause for the higher incidence of CVT in our country. 
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These multifactorial causes could be cause for the higher prevalence of 
CVT in pregnancy and puerperium in the present study .None of our 
patients had any history suggesting thrombotic tendencies. 
 
Present study has revealed a higher prevalence of CVT around 
58% in multiparous in accordance with various Indian studies (ChopraJS, 
BanerjeeAK 1989). 66% of cases presented in the second week                    
(8-14days) (p-0.01-stastically significant). 
 
Extreme diversity in clinical presentation makes it a challenge to 
diagnose CVT on clinical grounds. In the present study headache was 
found to be the universal symptom in 94% of cases (T-0.57-stastically 
significant), this is in accordance with various studies (Dutch-
European2001; Mehta, Muthukrishnan2004). Headache was invariably 
accompanied by seizures 64%, focal deficits 16% and altered sensorium 
12%.Thus headache presenting as the only sign of CVT is comparatively 
rare, in accordance with other studies (Deker, Steiner 2000; Saneto, 
Kinkel 2000). 
 
Papilledema was detected to be the commonest sign occurring in 
56% cases followed by focal deficits in 28% cases. The focal deficits 
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was in the form of hemi paresis, no cases presented paraparesis or  
quadriparesis. 26% of the hemiparesis was left sided, the cause of this 
predominance is not known. 
 
The diagnosis of CVT often requires neuroimaging. In the present 
study on cranial CT 52% had venous infarcts (T-0.3-ststistically 
significant). All the venous infarcts were hemorrhagic. The classical delta 
sign was seen in 20% cases. CT was detected to be normal in 20% cases, 
in accordance with other studies (Ameri 1992; Bousser MG 2000). 
 
The use of Magnetic resonance venogram has revolutionized the 
diagnosis of CVT .It has lead to rapid, noninvasive diagnosis of CVT and 
now is considered the gold standard .In the present study Superior sagittal 
sinus was detected to be the commonest venous channel involved in 74% 
cases, 22% in isolation and 52% in association with other venous 
channels, this is in accordance with various studies (Dormont1994; 
kalbag1967; Mehta, Muthukrishnan2004). This manifested as raised 
intracranial tension. In the 20% cases that had normal cranial CT, MRV 
detected changes and venous sinus involvement in all the cases .Thus 
20% of cases could escape detection and treatment delayed if CT alone is 
used as the only neuroimaging. 
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Anemia (Hb<12g%) was detected in 30% of cases, of which 
28%were puerperal. Anemia has been recognized in most obstetric series 
of CVT (Bansal BC, Gupta RR, Srinivasan-1983), this deserves further 
studies to clarify its role in pathogenesis of CVT. 
 
The role of Heparin in the management of CVT has been a matter 
of controversy. It’s effectiveness, even in hemorrhagic venous infarcts 
has been extensively studied and recommended by various authors 
(Einhaupl 1991, Cepri 1998, Nagarajan 1998).Though most series have 
used high dose heparin as a continuous infusion in management of CVT 
,limiting the use of low dose heparin(5000u s.c 8th hourly) to puerperal 
cases ,in the present study all 50 cases were   treated with unfractionated 
Heparin 5000 i.v 8th hourly. All patients received oral anticoagulant for 
3months.No complications were detected as a result of treatment regimen 
employed in the present study and proved to be effective. 
 
Mortality in the present study is 8%, correlating with that of 
literature (11%). Most of these cases, presented with raised intracranial 
tension, altered level of consciousness ,hemorrhagic venous infarcts and 
involvement of superior sagittal thrombosis on MRV. Thus presentation 
with altered level of consciousness could portend poor prognosis. 
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Thus CVT should be strongly considered in all cases presenting 
with a neurological problem, especially in the setting of pregnancy and 
puerperium. Neuroimaging with magnetic resonance venogram and 
treatment with heparin and search for the underlying cause is strongly 
recommended.                 
83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion  
84 
 
CONCLUSION OF THE STUDY 
 
 Cortical venous thrombosis was common in the age group of            
22-25 years, with an average age of presentation at 24 years. It is more 
common among pregnancy and puerperium. Among puerperal cases it 
was common among multiparous, most cases were second para. Most 
cases of puerperal CVT presented in the second week.  
 
Headache was the universal symptom, and usually occurred in 
association with other symptoms like seizures, visual disturbances and 
focal deficits. Papilledema was the commonest sign.  
 
Majority of patients had hemorrhagic venous infarct on cranial CT. 
It was normal in 10 cases. 20% of patients with normal cranial CT had 
changes in the magnetic resonance venogram. Thus MRV is of great 
diagnostic utility and these 20% cases could escape detection if CT alone 
is used as the only neuro imaging modality. Commonest venous sinus 
involved in MRV was superior sagittal sinus and transverse sinus. 
Mortality was low (8%) and most cases had excellent recovery.   
 
 
 
 
85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bibliography 
86 
 
BIBLIOGRAPHY 
 
1. Ribes MF.   FRENCH Medical Journal 1825; 3:5 
2.  Aberocombei J. Superior sagittal thrombosis in puerperium 83. In 
pathological and practical Researches of the Brain and Spinal 
Cord.Edinburgh 1828 ; 83-85 cited by Donaldson JO ed; Neurology 
of pregnancy, Philadelphia,1978. 
3.  Kalbagh RM,Woif AL. Etiology of cerebral venous thrombosis in 
cerebral venous thrombosis: Oxford University Press, London 1967; 
pp238.  
4.  Bianchi D, Maeder P, Bogousslavesky J, et al. Diagnosis of  CVT 
with routine magnetic resonance, an update. Eur Neurol 1998; 
40(4):79-90 
5.  Hulcelle PJ, Dooms GC, Mathurin P, Cornelis G. MRI assessment 
of  unsuspected dural sinus thrombosis. Neuroradiology. 
1989;31:217-221. 
6.  Sze G, Simmons B, Krol G, Walker R, Zimmerman RD, Deck MDF. 
Dural sinus thrombosis: verification with spine echo technics. AJNR 
Am J Neuroradiol. 1988; 9: 679-686. 
87 
 
7.  Nagaraja D, Tally AB. Stroke in the young in progress in clinical 
Neurosciences. Edt.publ Sinha KK, Ranchi 1988;2: 129-45. 
8.  Chopra JS, Prabhakar S. Clinical features and risk factors in stroke 
in young. Neurl Scandivia 1979; 43: 289-300. 
9.  Abraham J, Shetty C, Joss C. Stroke in the young. Stroke  1971; 2: 
258-66. 
10.  Bansal BC, Gupta RR, Prakash C. Stroke during pregnancy and 
puerperium in young females below the age of 40 as a result of 
cerebral venous/venous sinus thrombosis. Jpn Heart J. 1980;21: 171-
183. 
11.  Srinivasan K. puerperal cerebral venous arterial thrombosis. Semin  
Neural 1988; 8: 222-225. 
12.  Chopra JS, Banerjee AK. Primary intracranial sinovenous occlusions 
in youth and pregnancy. In:  Vinken PJ, Bruyn GW, Klawans HL, 
eds. Handbook of Clinical Neurology, vol 10: Vascular Diseases, 
part II. New York/Amsterdam: Elsevier Science Publishing Co. Inc; 
1989: 425-452. 
13.  Srinivasan K.  Stroke in the young.Neurology in India 1988; 36: 
189-94. 
88 
 
14. Srinivasan K.Cerebral venous and arterial thrombosis in pregnancy 
and peurperium.Angiology 1983;134: 737-46. 
15. De Bruijin SF, Stam J, Koopman MM, Vandenbroucke JP. Case 
control study of risk of Cerebral  sinus Thrombosis in OCP users 
and in carriers of hereditary prothrombolic condition. The CVT 
study group. BMJ 1998; 316; 589-92. 
16.  Bousser M.G; Cerebral venous thrombosis,diagnosis and 
management. J Neural.2000; 247: 252-58. 
17.  Peter M.Tzourio C, Ameri A, Bousser MG; Long- term prognosis in 
CVT, Follow up of 77 patients; Stroke 1996; 27: 243-246. 
18.  Stolz E, Kemkes-MMatthes B, Hahn M, et al;Screening for 
thrombophilic risk factors among 25 German patients with CVT. 
Acta Neural Scand 2000; 102: 31-36. 
19.  Bousser MG, Chiras J, Sauron B, Castaigra P. Cerebral venous 
thrombosis-review of 38 cases. Stroke 1985; 16: 199-213. 
20.  Carhuapoma JR, Mitsias P, Levine R.S; Cerebral venous thrombosis 
and anticardiolipin antibodies, Stroke 1997; 28: 2363-2369. 
21.  Bousser MG;  CVT, Nothing, heparin or local thrombolysis ? Stroke 
1999;30:481-483. 
89 
 
22.  de Bruin S, de Haan R, Stam J. Clinical features and prognostic 
factors of CVT in a prospective series of 59 patients. J Neurol 
Neurosurg Psychiat 2001; 70: 105-8. 
23.  Barnett HJM, Hyland HH; Noninfective intracranial venous 
thrombosis.Brain 1953; 76: 36-45 
24.  Ameri A, Bousser MG.Cerebral venous sinus thrombosis. Neurol 
Clin 1992; 10:87-111. 
25.  Roos KL, Pescuzzi RM, kuharik MA, Shapiro AD, Manco-Johnson 
MJ. Postpartum intracranial venous thrombosis associated with 
dysfunctional protein C and deficiency of protein S. Obstet Gynecol 
1990; 76:492-4. 
26.  Martin J, Sheehan H.Primary thrombosis of cerebral veins 
(following childbirth). Br.Med J 1941; 1:349-53. 
27.  Canu C, Barinagarrementeria F. CVT associated with pregnancy and 
puerperium: a review of 67 cases. Stroke 1993; 305:28-35. 
28.  Huges CRV. The antiphospholipid syndrome. Lancet 1993; 342: 
341-4. 
29.  Deschiens M, Conard J, Horellou M, Ameri A, Preter M, Chedu F. 
Coagulation studies, factor V Leiden and anticardiolipin antibodies 
90 
 
in 40 cases of Cerebral venous sinus thrombosis. Stroke 1996; 27: 
1724- 27:1724-30. 
30.  Pasquale LR, Moster ML, Schmaier A. Dural sinus thrombosis with 
abnormalities of protein S and fibrinogen. Arch Ophthalmol 1990; 
108: 644. 
31.  HauserD, Barzilai N, Zalish M, Pollack A. Bilateral pailloedema 
with retinal hemorrhages in association with cerebral venous sinus 
thrombosis and paroxysmal nocturnal hemoglobinuria. Am J 
Ophthalmol 1996; 122: 592-3. 
32.  Feldenzer JA, Bueche MJ, Venes JL, Gebarski SS. Superior sagittal 
sinus thrombosis with infarction in  sickle cell trait. Stroke 1987;; 
18:656-60. 
33.  Schwab FJ, Peyster RG, Brill CB. CT of cerebral venous sinus 
thrombosis in a child with homocystinuria.paediatric radiol 
1987;17;244-5. 
34.  Akatsu H, Vaysburd M, Fervenza F, Peterson J, Jacobs M. Cerebral 
venous thrombosis in nephrotic syndrome. Clin Nephrol 1997; 48: 
317-20. 
91 
 
35.  David RB, Hadfield MG,  Vines FS, Maurer HM, Dural sinus 
occlusion in leukemia .Peadiatrics 1975, 56:793-6. 
36.  Ellie E, Beoran Y, Brunet R. Paraneoplastic cerebral venous 
thrombosis. France Review Neurology 1993; 149: 297-9. 
37.  Reddingius RE, Patte C, Couanet D, kalifa C, Lemerle J. dural sinus 
thrombosis in children with cancer. Med Pediatr Oncol 1997; 29: 
296- 302. 
38.  Sigsbee B; Deck MD; Posner JB. Non metastatic superior sagittal 
sinus thrombosis complicating systemic cancer. Neurology 1979; 
29:139-46. 
39.  Ohata K; Hque M, Morino M, Nagai K, Nisho A, Nishijima Y, 
Hakubs A. Occlusion of the sigmoid sinus after surgery via the 
presigmoidal-transpetrosal approach. J Neurosurg 1998; 89: 575-84. 
40.  Saneto P.R,Samples S, Kinkel P. Traumatic intracerebral venus 
thrombosis associated with an abnormal golf swing, Headache 2000: 
40 595-598. 
41.  Wassermann D. Acute paranasal sinusitis and cavernous sinus 
thrombosis. Arch Otolaryngol 1967; 86: 205-9. 
92 
 
42.  Grafstein E, Fernandes  CM, Samoyloff S. Lateral sinus thrombosis 
complicating mastoiditis. Ann Emerg Med 1995; 25:420-3. 
43.  Murthy JMK, Chopra JS, Malik SR et al.Clinico-pathological 
correlates in autopsy in pyogenic meningitis.Ind J Med Res 1883; 
78: 234-52. 
44.  Mathew NT, Myers JS. Taori CM  et al. Internal carotid artery 
thrombosis in cavernous sinus thrombosis. Arch Neuro 1971; 24: 
11-5. 
45.  Kelly MA, Gorelick PB, Mirza D.  The role of drugs in the etiology 
of stroke. Clin Neuropharmacol 1992; 15: 249- 75. 
46.  Buchanan DS, Brazinsky JH. Dural sinus and cerebral venus 
thrombosis: incidence in young women receiving oral 
contraceptives. Arch Neurol 1970;22:440-4. 
47.  Srachan R, Hughes D, Cowie R. Thrombosis of the straight sinus 
complicating hormone replacement therapy. Br.J Neurosurg 1995; 
9:805-8. 
48.  Jaillard AS, Hommel M. Venous sinus thrombosis associated with 
androgens in a healthy young man. Stroke 1994; 25:212-13.  
93 
 
49.  Rothwell PM, Grant R. Cerebral venous sinus thrombosis induced 
by ‘ ecstasy’. J Neurol Neurosurg Psychiatry 1993;56:1035. 
50.  Meyer-Lindenberg A, Quenzel EM, Bierhoff E, Wolf h, Schindler E, 
Biniek R. Fatal cerebral venous sinus thrombosis in heparin induced 
thrombotic thrombocytopenia. Eur Neurol 1997;37:191-2. 
51.  Musio F, Older SA, Jenkins T, Gregorie em. Case report: CVT  as a 
manifestation of acute ulcerative colitis. Am J Med Sci 
1993;24:1880-4. 
52.  Byrne JV, Lawton CA. Meningeal sarcoidosis causing intracranial 
hypertension secondary to dural sinus thrombosis. Br. J.Rdiol 
1983;56:755-7. 
53.  el-Ramahi KM, al-Kawi MZ.Papiloedema in Bechcet’s disease; 
value of MRI in diagnosis of dural sinus thrombosis. J Neurol 
Neurosurg Psychiatry 1991; 54:826-9. 
54.  Shiozawa Z, Yoshida M, Kobayashi K, Tsunoda S, Mano T. 
Superior sagittal sinus thrombosis and systemic lupus 
erythematosus. Ann Neurol 1986;20:272. 
94 
 
55.  Urban E, Jabbari B, Robles H.Concurrent cerebral venous sinus  
thrombosis and myeloradiculopathy in Sjogren’s syndrome. 
Neurology 1994;44:554-6. 
56.  Srinivasan K. Puerperal CVT  Seminar in Neurology 1988;8:222-5. 
57.  Dalal PM. Stroke in India. Jap Heart Jour 1982;46:621-5. 
58.  Daif A, Awada A, Al-Rajeh et al.Malibary CVT in adults a study of 
40 cases from Saudi Arabia. Stroke 1995;26:1193-5. 
59.  Prakash C, Singh S. CVT in puerperium. J Ass Phys India 
1960;8:363-5. 
60.  Srinivasan K, Ramamurthy B. Neurological disorder in pregnancy 
and puerperium. J Ass Phy India 1971; 19:705-07. 
61.  Janaki S, Thomas L. Neurological complications in pregnancy and 
puerperium. Neurology India 1963;11:128-30. 
62. Dibakdsib JO. Cerebrovascular disease. In: Donaldson JO. Ed. 
Neurology of pregnancy. Philedelphia, Pa: WB Saunders: 1978: 
135-34. 
63. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum 
stroke and intracranial venous thrombosis. Stroke 2000; 31:1274-82. 
95 
 
64.  Cumming AM, Tait RC, Fildes S, Yoong A, Keeny S, Hay CRM. 
Development of resistance to activated protein C during pregnancy. 
Br. J Haematol 1995;90:725-7. 
65. Vandenbroucke J. Cerebral sinus  thrombosis and oral 
contraceptive(editorial). BMJ1998;317:878-9. 
66.  Prakash C,Arya RK, Singla KP et al.Platelet adhesiveness and serum 
lipids in CVT. J Ass Phy Ind 1970;18:816-9. 
67.  Bansal BC, Prakash C, Gupta RR et al. Study of serum lipids and 
fibrinolytic activity in CVT during puerperium. Am J Obst Gyn 
1974;119(8):1079-82. 
68.  Bansal BC, Prakash C.Serum lipids, platelet and fibrinolytic activity 
in cerebrovascular disease. Stroke 1978;9:137-9. 
69.  de Bruijjb S, Stam J, Kaappelle L. Thunderclap headache as the first 
symptom of cerebral venus sinus thrombosis. Lancet 1996; 
348:1623-5. 
70.  Deker R.R, Steiner I. Isolated intracranial hypertension as the only 
sign of cerebral venous thrombosis. Neurology 2000;54:2030. 
96 
 
71.  Jacobs K, Moulin T, Bougousslavsky J, Woimant F, Dehaene I, Tatu 
L, Besson G, Assouline E, Casselman J. The stroke syndrome of 
cortical vein thrombosis. Neurology 1996;47:376-82. 
72.  Hayley EC, Brashear HR, Barth JT, Cail WS, Kassell N. Deep 
cerebral venous thrombosis: clinical, neuroradiological and 
neuropsychological correlates. Arch Neurol 1989; 46:337-40. 
73.  Nayak AK, Karnad D, Mahajan MV, Shah A, Meisheri YV. 
Cerebellar venous infarction in chronic suppurative otits media: a 
case report with review of four other cases. Stroke 1994;25:1058-60. 
74.  Banerjee AK, Chopra JS, Sawhney BB. Puerperal cerebral venous 
thrombosis. Study of autopsy material. Neurology  Journal of Indian 
Academy of Clinical Medicine.vol.5 No.1 61 India 1973;21:19-22. 
75.  Tsai FY, Wang AM, Matovich VB, Lavin M, Berberian B, 
Simonson tm, Yuh WT.MR staging of acute dural sinus thrombosis: 
correlation with venous pressure measurements and implications for 
treatment and prognosis. Am J Neuroradiol 1995;16:1021-9. 
76.  Diaz JM, Schiffman JS, Urban ES, Maccario M. Suprior sagittal 
sinus thrombosis and pulmonary embolism: a syndrome 
rediscovered. Acta neurol Scand 1992;86:390-6. 
97 
 
77.  Hladky JP, Leys D, Vantyghem MC, Furby A, Leclerle X, Dupard 
T, Lefebvre J. Early hypopituitarism following cavernous sinus 
thrombosis: total recovery within 1 year. Clin Neurol Neurosurg 
1991;93:249-52. 
78.  Houser OW, Campbell JK, Campbell RJ, Sundt TM. Arteriovenous 
malformation affecting the transverse dural venous sinus: an 
acquired lesion. Mayo Clin Proc 1979;54:651-61. 
79.  Brant-Zawadzki M, Chang ZY, Meccarty GE. Computed 
tomography in dural sinus thrombosis. Arch Neuro 1982. 
80.  Maheswari MC, Bhargave S. Evaluation of peripartum stroke by 
C.T. Scan. Clinical Radiology 1983;34:633-7. 
81. Rao KCVG; Knipp HC, Wagner EJ, CT Findings in cerebral sinus 
and venous thrombosis. Radiology 1981; 140:391-98. 
82. Bousser MG; Ross Russeu R.  CVT vol.1, London: WB Saunders 
1997; 175. 
83.  Patronas NJ, Duda EE, Mifakhrace M, Wolmann RL. Superior 
sagittal sinus thrombosis. Diagnosed by computed tomography. Surg 
Neurol 1981;15:11-14. 
98 
 
84.  Bouonanna F, Moody DM, Ball MR, Laster DW. Computer cranial 
tomographic findings in sino-venous occlusion. J Computer Assisted 
tomographic 1978;2:281-90. 
85.  Dormont D, Axionnat R et al. MRI in cerebral venous thrombosis. J 
Neuroradiology 1994;21(2):81- 99. 
86. Vogl T. Bergman C, Villringer A, Einhaupal K, Lissner J, Felix R. 
Dural sinus thrombosis:value of venous MRA for diagnosis and 
follow up. Am J Radiology 1994;162:1191-8. 
87.  Padayachee TS, Bingham JB, Grave MJ. Dural sinus thrombosis. 
Diagnosis and follow up by magnetic resonance, angiography and 
imaging. Neurology 1991;33:165-7.  
88. Provenzale JM, Joseph GJ, Barboriak DP. Dural sinus thrombosis; 
findings on CT and MR imaging and diagnostic pitfalls. Am J 
Radiology 1998;170:777-83. 
89. Barnes BD, Winestock DP. Dynamic radionuclide scanning in the 
diagnosis of thrombosis of superior sagittal sinus. Neurology 
1977;27:656. 
99 
 
90.  Lalive PH, de Moerloose P, Lovblad K, et al: Is measurement of D-
dimer useful in the diagnosis of CVT? Neurol 2003 Oct 28; 
61(8):1057-60. 
91.  Einhaupl EM, Villringer A et al. Heparin in cerebral venous 
thrombosis. Labcet 1991;338:597-600. 
92.  Dirocco C,Lannelli A, Leonac G et al. Heparin-urokinase treatment 
in aseptic dural sinus thrombosis. Arch Neuro 1981;38:431-5. 
93.  Cepri S; Gangeni A, Campolo C et al. High dose heparin plus 
warfarin administration in non traumatic dural sinus thrombosis- a 
clinical and neurological study. J Neurosurgical Scie 1998;42(1):         
23-32. 
94.  Nagaraja D,Tlly AB, Hardas VT et al. Heparin in haemorrhagic 
infarction in CVT. J Ass Phy Ind 1998;46:706-07. 
95.  Bruuckler MB, Volleret-Rogenhofer H, Wagner M, Steilbauer-
Felber S, Trenkler J, Deisenhammer E, Aichner F. Heparin treatment 
in acute cerebral sinus thrombosis: a retrospective clinical and MR 
analysis of 42 cases. Cerebrovascular Dis 1998;8:331-3. 
100 
 
96.  Einhaupl K, Villringer A, Meister W, Mehraein S, Garner C, 
Pellkofer M, Haberl R, Pfister HW, Schmiedek P. Heparin treatment 
in venous sinus thrombosis. Lancet 1991;338:597-600. 
97. Levine SR, Twyman RE, Gilman S. The role of anticoagulation in 
cavernous sinus thrombosis. Neurology 1998 Apr; 38(4):517-22. 
98. Scott JA, Pascuzzi RM, Hall PV, Becker GJ.Treatment of dural 
sinus thrombosis with local urokinase infusion. J Neurosurg 1988; 
68:284-7. 
99.  Horowitz M, Purdy P, UNwin H, Carstens G, Greenlee R, Hise J, 
Kopitnik T, Batjer H, Rollins N,Samson D. Treatment of dural sinus 
thrombosis using selective catheterization and urokinase. Ann 
Neurol 1995;38:58-67. 
100.  Kim SY, Suh JH. Direct endovascular thrombolytic theraphy for 
dural sinus thrombosis: Infusion of alteplase. Am J Neuroradiol 
1997; 18:639-45. 
101.  Frey JL, Muro GJ, Mcdougall CG, Dean BL, Jahnke HK. CVT: 
Combined intra thrombus rtPA and i.v heparin. Stroke 1999;  
30:489-94. 
101 
 
102.  Benamer HTS, Bone I.  CVT: anticoagulants or thrombolytic 
therapy? J Neurol Neurosurg  Psychiat 2000;69:427-30. 
103.  Derex L, Philppean F, Nighoghossian N et al. Postpartum CVT. J 
Neurol Neurosurgery 1988;65(5):80-2. 
104.  Nagpal RD,. Dural sinus and CVT. Neurosurg Rev 1983;6:155-60. 
105.  Zilkha A, Stenzler SA, Lin JH. Computed tomography of the 
normal and abnormal superior sagittal sinus. Clin Radiol 
1982;33:415-25. 
106.  Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis 
in CVT: follow up of 77 patients. Stroke 1996;27:243-6. 
107. de Bruuijn SF, Budde M, Teunisse S, de Haan RJ. Long term 
outcome of cognition and functional health after cerebral venous 
sinus thrombosis. Neurology 2000;54:1687-9. 
108.  Dormont D, Anxionnat R, Evrard S, Louaillle C, Chiras J, Marsault 
C. MRI in CVT. J neuroradiol 1994;21:81-99. 
109.  Krristensen B, Malm J, Markgren P, Ekstedt J. CSF hydrodynamics 
in superior sagittal sinus thrombosis. J Neurol Neurosurg Psychiat 
1992;55:287-93. 
102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
103 
 
COIMBATORE MEDICAL COLLEGE AND HOSPITAL 
PROFORMA 
 
 
NAME :                                          AGE:              SEX:                  I.P NO:                     
 
 
 D.O.A:                                           D.O.D:                             NEURO NO:                      
  
 
COMPLAINTS: 
 
 
 
 
HISTORY OF:  
 
                             FEVER: 
                             EAR DISCHARGE 
                             DIARRHOEA 
                             HEMORRHAGIC TENDENCIES 
                             THROMBOTIC TENDENCIES  
                             P.I.H    
                             RECURRENT PREG LOSS 
                             MALIGNANCIES 
                             PROLONGED IMMOBILISATION  
                             CHRONIC DRUG INTAKE 
 
OBSTETRIC H/O:          G          P               L.C.B 
 
                                     
EXAMINATION 
 
GENERAL PHYSICAL EXM: 
 
PULSE:                    B.P                  TEMP               RESP RATE 
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C.V.S : 
 
R.S /E.NT   :  
 
PER ABDOMEN  : 
 
CENTRAL NERVOUS SYSTEM  : 
 
LAB DIAGNOSIS : 
 
1. COMPLETE BLOOD COUNT : 
 
2. PERIPHERAL SMEAR : 
 
3. URINE ROUTINE : 
     
                                                                 
4. BLOOD UREA : 
 
          SUGAR : 
 
          SREUM CREATININE : 
 
5. LIVER FUNCTION TESTS : 
 
6. PROTHROMBIN TIME : 
 
7. a.P.T.T.: 
 
8. VDRL/HIV: 
 
9. C.S.F.ANALYSIS: 
 
10. C.T. BRAIN-PLAIN/CONTRAST: 
 
11. M.R.V: 
 
 
 
PROGNOSIS : 
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F GTCS
1 23 P A P A A P A A A A A A A A A A A - P1 15d Anemia N N N N N N Stupor
L Hemiparesis
L VII Palsy
2 25 P A P A A A A A A A A A A A A A A - P2 8d Anemia N N N N N N B/L papilledema
3 25 A A A P A A A A A A A A A A A A A - P2 3d Anemia N N N N N N L Hemiparesis
4 18 P A P A A A A A A A A A A A A A A - P1 15d Anemia N N N N N N Normal
5 26 P A P A A P A A A A A A A A A A A - P1 10d N N N N N N N Coma. Fundus N
6 20 P A A P A A A A A A A A A A A A A - P1 10d N N N N N N N L Hemiparesis
7 23 P A P P A A A A A A A A A A A A A - P1 30d N N N N N N N L Hemiparesis B/L 
papilledema
8 25 P P A A A A A A A A A A A A A A A - P1 10d N N N N N N N Normal
9 24 P A A A P A A A A A A A A A A A A - P1 10d Anemia N N N N N N B/L papilledema
10 18 P A P A A P A A A A A A A A A A A - P1 8d N N N N N N N Stupor
B/L papilledema
11 20 P A A A P A A A A A A A A A A A A - Nulli - Anemia N N N N N N B/L papilledema
12 29 P A A A P A A A A A A A A A A A A - P1 2yrs N N N N N N N B/L papilledema
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F GTCS
13 22 P A A A A A A A A A A A A A A A A - P2 9d N N N N N N N B/L papilledema
14 25 P - P A A A A A A A A A A A A A A - P2 15d Anemia N N N N N N B/L papilledema,
Stupor 
15 27 P P A A A A A A A A A A A A A A A - P1 3d N N N N N N N L Hemiparesis
L VII Palsy
16 26 P P A A A A A A A A A A A A A A A - P1 11d Anemia N N N N N N Normal
17 25 P P A A A A A A A A A A A A A A A - P3 15d N N N N N N N B/L papilledema
18 21 P A P A A A A A A A A A A A A A A - P2 10d N N N N N N N Normal
19 21 P A P A A A A A A A A A A A A A A - P1 10d Anemia N N N N N N Normal
20 23 P A P P A A A A A A A A A A A A A - P2 30d N N N N N N N L Hemiparesis
L VII Palsy
21 21 P P A A A P A A A A A A A A A A A - P1 22d N N N N N N N Coma. 
B/L papilledema
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F GTCS
22 18 P A P A A A A A A A A A A A A A A - P2 20d N N N N N N N B/L papilledema
23 34 P P A P A A A A A A A A A A A A A - Nulli - N N N N N N N L Hemiparesis
24 22 P A A A A A A A A A A A A A A A A - P2 15d N N N N N N N B/L papilledema
25 24 A A P A A A A A A A A A A A A A A - P2 5d Anemia N N N N N N Normal
26 21 P A P A A A A A A A A A A A A A A - P1 3d N N N N N N N B/L papilledema
27 20 P A A P A A A A A A A A A A A A A - P1 10d N N N N N N N L Hemiparesis
B/L papilledema
28 22 P P A A A A A A A A A A A A A A A - P2 30d Anemia N N N N N N Normal
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F GTCS
29 20 P A P A A A A A A A A A A A A A A - P1 11d N N N N N N N Normal
30 23 P P A A A A A A A A A A A A A A A - P2 14d N N N N N N N L Hemiparesis
31 26 P A A A A A A A A A A A A A A A A - P2 10d N N N N N N N B/L papilledema
32 32 P A P A A A A A A A A A A A A A A - P4 4d N N N N N N N B/L papilledema
33 20 P A P A A A A A A A A A A A A A A - P2 10d N N N N N N N B/L papilledema
34 20 P A P A A A A A A A A A A A A A A - P3 8d N N N N N N N L Hemiparesis
35 18 P A A A P A A A A A A A A A A A A - P1 10d N N N N N N N B/L papilledema
36 22 P A A P P A A A A A A A A A A A A - P2 12d N N N N N N N B/L papilledema
R Hemiparesis
37 25 P A P A A A A A A A A A A A A A A - P3 8d Anemia N N N N N N Normal
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F GTCS
38 30 P A A A A A A A A A A A A A A A A - P4 12 Anemia N N N N N N B/L papilledema
39 19 P A P A P A A A A A A A A A A A A - P1 10d N N N N N N N B/L papilledema
40 35 P A A A P A A A A A A A A A A A A - P1 10d N N N N N N N B/L papilledema
41 20 P A P A A A A A A A A A A A A A A - P2 10d N N N N N N N L Hemiparesis
42 22 P A A A P A A A A A A A A A A A A - P2 13d N N N N N N N B/L papilledema
43 18 P A A A A A A A A A A A A A A A A - P1 10d N N N N N N N Normal
44 25 A A p A A P A A A A A A A A A A A - P1 10d N N N N N N N L Hemiparesis
45 27 P A A A P A A A A A A A A A A A A - P3 14d N N N N N N N Stupor
B/L papilledema
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.
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F GTCS
46 20 P A A A P A A A A A A A A A A A A - P1 8d N N N N N N N B/L papilledema
47 22 P A P P A P A A A A A A A A A A A - P2 10d N N N N N N N Stupor
B/L papilledema 
L Hemiparesis
48 24 P P A A A A A A A A A A A A A A A - P2 12d N N N N N N N B/L papilledema
49 30 P A P A A A A A A A A A A A A A A - P4 14d Anemia N N N N N N Normal
50 28 P A A A P A A A A A A A A A A A A - P3 7d Anemia N N N N N N B/L papilledema
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1 7.0 5200 P70
L30
10 3.0 2.0 Microcytic 
Hypochromic
N 20 80 1.0 N 10 30 NEG NR N Hemorrhagic Infarct R Frontal + + - - - Venous Infarct with Surrounding 
Edema R Frontal
G
2 7.6 4600 P60
L40
15 5.0 1.5 Microcytic 
Hypochromic
N 22 86 1.0 N 15 29 NEG NR ND Hemorrhagic Infarct B/L Frontal + + + - - -
G
3 6.9 5000 P70
L30
14 4.2 2.0 Microcytic 
Hypochromic
N 21 100 0.8 N 14 27 NEG NR N Hemorrhagic Infract L parieto 
occipital 
- + + - - -
G
4 8.0 4100 P66
L32
E
12 3.6 1.8 Microcytic 
Hypochromic
N 20 96 1.3 N 15 30 NEG NR N Hemorrhagic 
Infarct R Frontal 
+ - - - - -
G
5 12.0 5200 P70
L30
10 30.0 2.0 N N 24 98 0.8 N 15 28 NEG NR N Hemorrhagic 
Infarct L Frontal 
+ - - - - -
D
6 13.0 4000 P60
L40
10 3.2 2.5 N N 26 88 0.8 N 16 24 NEG NR N Normal + + + - - -
G
7 12.0 6100 P75
L25
13 4.0 2.0 N N 20 84 0.9 N 15 26 NEG NR ND Normal + + - - - Venous Infarct with Vasogenic 
Edema R Para Sagittal
G
8 12.0 5600 P60
L38
E2
14 4.0 2.0 N N 21 82 1.0 N 15 31 NEG NR N Hemorrhagic 
Infarct L Parietal 
- + + - - Extension IJV + Venous 
Hemorrhagic Infract Parieto 
Temporo Occipital G
9 7.0 5200 P70
L30
10 3.5 2.0 Microcytic 
Hypochromic
N 20 90 1.0 N 15 30 NEG NR ND Normal - + + - - -
G
10 12.0 5600 P70
L30
12 4.0 1.8 N N 18 94 1.5 N 11 32 NEG NR ND Hemorrhagic 
Infarct L Temporo Occipital
- + + - - Large Temporo 
Occipital Hematoma with 
subdural Hemorrhage G
11 7.2 6000 P68
L32
12 4.0 2.0 Microcytic 
Hypochromic
N 22 100 0.8 N 14 28 NEG NR ND Delta Sign + + + - - Minimal  Subarachnoid 
Hemorrhage over 
Tentorium Cerebelli G
12 13.0 7000 P70
L30
10 3.6 2.0 N N 19 98 1.0 N 15 26 NEG NR ND Hemorrhagic Infarct L Temporal - + - - - -
G
P
r
o
g
n
o
s
i
s
S
S
S
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S
S
S
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V
D
C
V ParenchymaCranial CT Plain /  Contrast
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13 12.0 6600 P60
L40
10 3.0 2.5 N N 21 86 1.0 N 15 25 NEG NR ND Delta Sign with  Hemorrhagic 
Infarct R Parietal 
+ - - - - -
G
14 8.0 5400 P70
L30
11 4.1 2.0 Microcytic 
Hypochromic
N 22 80 0.8 N 13 30 NEG NR ND Hypodensity both 
Thalamo, Capsulo, Gangionic region 
(? Deep venous involv)
- - - - + -
D
15 12.0 5100 P70
L30
10 3.9 2.0 N N 20 84 0.8 N 15 30 NEG NR N Delta Sign with  Hemorrhagic 
Infarct R Frontal with surrounding 
Edema
+ + + - - Hemorrhagic 
Infarct R Frontal with 
surrounding Edema G
16 7.6 5600 P70
L30
12 3.5 2.0 Microcytic 
Hypochromic
N 22 90 1.0 N 15 32 NEG NR N Hemorrhagic Infarct L Frontal + - - - - -
G
17 12.0 7000 P60
L40
10 5.0 2.0 N N 20 88 0.8 N 16 30 NEG NR ND Hemorrhagic Infarct L Frontal + - - - - -
G
18 13.0 7200 P66
L34
10 4.0 1.5 N N 20 101 1.3 N 14 29 NEG NR N Delta Sign + + - - - -
G
19 8.0 6600 P72
L28
9 3.6 2.0 Microcytic 
Hypochromic
N 21 103 1.0 N 15 28 NEG NR N Hemorrhagic Infarct L Parieto
Temporal 
+ + - - - -
G
20 13.0 5000 P70
L28
E2
10 3.0 1.8 N N 28 84 1.2 N 13 30 NEG NR N Hemorrhagic Infarct L Parietal + - - - - -
D
21 12.0 5200 P70
L30
13 4.9 2.0 N N 26 90 1.0 N 13 33 NEG NR ND Delta Sign Hemorrhagic 
Infarct B/L Frontal 
+ + - - - -
D
Complete Hemogram Magnetic Resonance Venogram
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22 12.0 6100 P66
L34
12 4.0 2.0 N N 20 96 1.4 N 12 34 NEG NR N Normal - + - - - -
G
23 13.0 7000 P66
L32
11 4.0 2.0 N N 27 100 1.0 N 14 30 NEG MN N Hemorrhagic 
Infarct R Parietal with Surrounding 
Edema
- - - + - Venous Infarct 
R Fronto Parietal 
G
24 13.0 8100 P72
L28
11 4.0 2.3 N N 25 101 0.8 N 15 32 NEG NR ND Normal + + + - - -
G
25 6.6 4600 P60
L40
10 5.0 2.5 Microcytic 
Hypochromic
N 24 88 0.8 N 12 29 NEG NR N Hemorrhagic  Infarct L Frontal - + + - - Sub acute Hematoma
with surrounding 
Edema with L Frontal
G
26 13.0 5000 P70
L30
10 5.0 2.0 N N 25 92 1.0 N 13 28 NEG NR ND Hemorrhagic  Infarct 
L Occipito Parietal
- + + - - -
G
27 12.0 5800 P70
L28
E2
9 4.0 2.0 N N 28 96 0.8 N 15 27 NEG NR ND Delta Sign + + - - - Hemorrhagic 
Infarct  R Parietal
G
28 7.5 5600 P60
L40
10 4.0 2.0 Microcytic 
Hypochromic
N 24 90 0.8 N 15 32 NEG NR N Ill defined Hypo 
density R Temporal 
with surrounding Edema 
+ + + + - R Temporal Venous Infarct with 
surrounding 
Edema Thrombus ext to IJV 
G
Complete Hemogram
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29 12.0 7000 P70
L30
10 3.5 2.0 N N 20 92 1.0 N 14 30 NEG NR N Hyper dense lesion with surrounding  
hypo dense area L Tempro Parietal 
- + + - - Thrombus ext 
to IJV, sub acute hematoma L 
temporal 
G
30 12.0 4000 P66
L34
12 4.0 3.0 N N 26 94 1.2 N 12 32 NEG NR N Delta Sign with Venous Infarct 
Fronto Parietal  
+ + - - - -
G
31 13.0 4900 P70
L30
10 4.0 2.0 N N 30 100 0.8 N 15 29 NEG NR ND Hemorrhagic Infarct R Temporal + + - - - -
G
32 11.8 5000 P68
L32
11 3.6 2.0 N N 28 101 0.8 N 12 27 NEG NR ND Hemorrhagic Infarct L Frontal + + - - - -
G
33 11.5 5200 P66
L32
E
10 3.9 2.0 N N 20 102 1.0 N 13 27 NEG NR ND Hemorrhagic Infarct R Frontal + + - - - -
G
34 12.1 6000 P70
L30
11 3.5 2.1 N N 24 105 1.2 N 13 29 NEG NR N Hemorrhagic Infarct B/L  Fronto 
Parietal 
+ + - - - Hemorrhagic 
Infarct B/L  Fronto Parietal 
G
35 12.2 6100 P60
L40
10 4.6 1.8 N N 22 99 1.3 N 14 28 NEG NR ND Delta Sign + - - - - -
G
36 13.0 4000 P68
L32
13 5.0 1.77 N N 26 88 0.8 N 15 32 NEG NR ND Normal + + + - - MInimal Subarachnoid 
Hemorrhage both parietal 
cerebral sulci G
37 8.0 5200 P70
L30
10 4.1 1.9 Microcytic 
Hypochromic
N 20 100 0.9 N 15 26 NEG NR N Normal - + + - - -
G
S
.
N
o
.
Complete Hemogram Magnetic Resonance Venogram
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38 8.0 5400 P77
L23
10 4.0 2.0 Microcytic 
Hypochromic
N 22 92 1.0 N 14 24 NEG NR ND Delta Sign + + + - - Partial Thrombus in IJV, Galen 
and Straight Sinus. Venous 
Infract R Thalamo Parietal G
39 12.0 5900 P80
L20
15 3.9 2.1 N N 22 89 1.2 N 12 22 NEG NR ND Hemorrhagic 
Infarct L Frontal 
+ + - - - -
G
40 12.0 6000 P70
L30
15 4.0 2.2 N N 26 86 1.3 N 13 32 NEG NR ND Delta Sign + - - - - -
G
41 12.0 6000 P70
L30
12 3.5 2.0 N N 22 90 0.8 N 15 30 NEG NR N Normal + + + - - -
G
42 13.0 5400 P60
L40
10 3.8 1.75 N N 24 102 103.0 N 14 32 NEG NR N Delta Sign + - - - - -
G
43 12.1 7000 P66
L34
10 4 2.1 N N 26 105 1 N 13 34 NEG NR N Hemorrhagic Infarct L Temporal - + + - - -
G
44 11.8 5900 P68
L32
11 3.5 1.9 N N 22 96 1 N 15 33 NEG NR N Hemorrhagic Infarct R Parietal + - - - - -
G
45 12 5000 P70
L30
15 4.2 2 N N 28 90 1.5 N 15 29 NEG NR ND Delta Sign + + - - - -
G
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46 12.6 6200 P68
L32
10 3.6 2.2 N N 30 92 1.5 N 14 28 NEG NR ND Delta Sign + + - - - Venous Infract R Thalmo Parietal 
with  Thrombus in Straight Sinus. 
G
47 12 7100 P60
L40
12 3.7 2.1 N N 32 94 0.8 N 13 29 NEG NR ND Hemorrhagic Infarct L Fronto Parietal + + - - - -
G
48 12 7000 P70
L30
10 3.5 1.9 N N 28 95 1 N 12 29 NEG NR ND Normal + - - - - -
G
49 6.8 5000 P60
L40
10 4.1 2 Microcytic 
Hypochromic
N 26 88 1.4 N 15 27 NEG NR N Normal + + + - - -
G
50 7 5500 P66
L34
12 4.2 2 Microcytic 
Hypochromic
N 22 87 1.3 N 15 26 NEG NR ND Delta Sign + + + - - MInimal Subarachnoid 
Hemorrhage both parietal 
cerebral sulci G
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* All patients had Focal deficits in form of Hemiparesis 
* All patients had visual disturbances in form of blurring of objects 
• Non – Puerperal Cases 
 
Normal Values  
LFT - SGOT- 0-35 U/L 
SGPT- 0-35 U/L 
SAP-40-100U/L 
S.Bilirubin - 0.3-1mg/dl 
S.Proteins - 6-8 gms/dl 
Albumin - 3.5-5.5 gm/dl 
Globulin - 2.5 gms/dl 
CSF   
Cells - <5WBC/miL 
Protein - 20-50mg/L 
Sugar - 40-70 mg/DL 
Chloride - 116-122 mmol/L 
Pressure - 50-180mmH2O 
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ABBREVIATIONS IN MASTER CHART 
 
  F - Focal 
GTCS - Generalised Tonic Clonic Seizures  
RPL - Recurrent Pregnancy Loss 
PIH - Pregnancy Induced Hypertension  
LCB - Last Child Birth 
LFT - Liver Function Test 
PT - Prothrombin Time 
aPTT - Activated Partial Thromboplastin Time 
A - Absent 
P - Present 
ND - Not Done 
SSS - Superior Sagittal Sinus  
TS - Transverse Sinus 
SS - Sigmoid Sinus 
CV - Cortical Vein  
DCV - Deep Cerebral Vein 
G - Good 
D - Death 
 
